Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-089-3
CAS number: 68515-47-9
There was no evidence of systemic toxicity from repeated dermal
exposures to MRD-69-4 as based on general appearance and behavior,
clinical laboratory studies, and gross and microscopic visceral
Compound effect was confined to gross and microscopic alterations of the
skin. Grossly, MRD-69-4 at the 0.5 ml/kg/day level produced generally
mild dermal irritation which was slightly more severe than irritation
produced by mineral oil at 2.5 ml/kg/day; at the 2.5 ml/kg/day level,
slight or moderate (abraded skin only) erythema and slight desquamation
were noted through the fifth week of application.
Histologically, skin sections showed slight acanthosis, slight
hyperkeratosis, and slight dermatitis of comparable severity in control
and compound-treated animals. Sections of kidney, liver, and skin from
control and test animals were comparable histologically; lesions
encountered were consistent with incidental disease.
In a six week dermal toxicity study, groups of four New Zealand White
rabbits received 24-hour daily applications of MRD-69-4 at 0.5 or 2.5
ml/Kg, five times a week, to the closely clipped intact (two animals per
group) or abraded (two animals per group) abdominal skin, wrapped with
gauze adhesive tape and fitted with neck collars. Control animals (three
males and one female) received mineral oil at 2.5 ml/Kg. Clinical signs
were recorded daily, haematology and urinalysis undertaken initially and
terminally, and histopathology was performed on the liver, kidneys and
skin. There was no evidence of systemic toxicity. Mild irritation was
observed at the application sites of animals treated with MRD-69-4,
although there was no difference in the severity of histopathological
skin changes apparent between test and control animals. The systemic
NOEL was considered to be 2.5 ml/kg/day (estimated to be 2500 mg/kg/day)
and the local NOAEL was considered to be 0.5 mg/kg/day (estimated to be
The dermal toxicity study was considered to be a suitable supporting
study for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again